← All indications
Lupus Erythematosus, Cutaneous
A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
Subtype terms (1)
More specific conditions that are subtypes of Lupus Erythematosus, Cutaneous in the MeSH hierarchy.
- Lupus Erythematosus, Discoid
17 drugs (12 approved, 5 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (3)
Phase 2 trials (17)
Phase 1 trials (16)
Other trials (2)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (18)
- Basilea Pharmaceutica
- Celgene
- Galapagos NV
- Gilead Sciences
- Immunomedics
- Pfizer
- Biogen
- Novartis
- Central South University
- Emory University
- University of Leeds
- Department of Defense
- University of Munster
- Government of China
- University of Duesseldorf
- National Institute for Health Research, United Kingdom
- National Natural Science Foundation of China
- Dermatology Foundation
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (2)